Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Hughes

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
BMJ Open|February 12, 2025
Rates, causes and predictors of all-cause and avoidable mortality in 514 878 adults with and without intellectual disabilities in Scotland: a record linkage national cohort studyEwelina Rydzewska, Dewy Nijhof, Laura Hughes, et al.
British Journal of Cancer|December 5, 2024
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapySanjay Popat, Adam Januszewski, Mary O'Brien, et al.
The Lancet Regional Health. Europe|March 17, 2023
More questions than answers to the diagnosis and management of cauda equina syndrome-Authors' replyJulie Woodfield, Ingrid Hoeritzauer, Aimun A B Jamjoom, et al.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2019
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung CancerJohn D Fenwick, David B Landau, Angela T Baker, et al.
The Lancet Regional Health. Europe|November 25, 2022
Presentation, management, and outcomes of cauda equina syndrome up to one year after surgery, using clinician and participant reporting: A multi-centre prospective cohort studyJulie Woodfield, Ingrid Hoeritzauer, Aimun A B Jamjoom, et al.
Arthritis Research & Therapy|November 20, 2010
Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional studyTed R Mikuls, Karen A Gould, Kimberly K Bynoté, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2016
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung CancerDavid B Landau, Laura Hughes, Angela Baker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2022
Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Alpha Variant-United States, 2021Marisa A P Donnelly, Meagan R Chuey, Raymond Soto, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
BMJ Open|February 12, 2025
Rates, causes and predictors of all-cause and avoidable mortality in 514 878 adults with and without intellectual disabilities in Scotland: a record linkage national cohort studyEwelina Rydzewska, Dewy Nijhof, Laura Hughes, et al.
British Journal of Cancer|December 5, 2024
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapySanjay Popat, Adam Januszewski, Mary O'Brien, et al.
The Lancet Regional Health. Europe|March 17, 2023
More questions than answers to the diagnosis and management of cauda equina syndrome-Authors' replyJulie Woodfield, Ingrid Hoeritzauer, Aimun A B Jamjoom, et al.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2019
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung CancerJohn D Fenwick, David B Landau, Angela T Baker, et al.
The Lancet Regional Health. Europe|November 25, 2022
Presentation, management, and outcomes of cauda equina syndrome up to one year after surgery, using clinician and participant reporting: A multi-centre prospective cohort studyJulie Woodfield, Ingrid Hoeritzauer, Aimun A B Jamjoom, et al.
Arthritis Research & Therapy|November 20, 2010
Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional studyTed R Mikuls, Karen A Gould, Kimberly K Bynoté, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2016
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung CancerDavid B Landau, Laura Hughes, Angela Baker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2022
Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Alpha Variant-United States, 2021Marisa A P Donnelly, Meagan R Chuey, Raymond Soto, et al.
Pageof 7